Skip to main content
Caplight Logo









Oculera Health

Oculera Health

Private
TurkeyHealthcare & Life Scienceshttps://www.oculera.health/

Last Round

Seed

Nov 24, 2025

Total Funding Raised

$3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Oculera Health is a medical device company that develops and manufactures virtual reality-based visual field analyzers for the diagnosis of eye conditions such as glaucoma and age-related macular degeneration.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Hardware, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

perimetryvisual field testingVR medical deviceophthalmology equipmentportable diagnosticsvirtual reality diagnosticseye care technologydigital healthmedical VRclinical screeningtele-ophthalmologymedtecheye trackingSaaS medical software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oculera Health Comparables

Compare Oculera Health with similar companies based on industry and business-model similarity.

Oculera Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PeriVision
93%
Olleyes, Inc.
92%
Virtual Vision Health
92%

Oculera Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 24, 2025

Key People

Founding team and executive leadership

Emre Bülbül

Co-Founder & COO

Founding Team

Hande Gulec

Co Founder & COO

Founding Team

Onur Kizilot

Co-Founder - Chief Strategy Officer (CSO)

Founding Team

Mert Keleş

Co-founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 19, 2026

    Grew 27% QoQ from 11 to 14 employees.

  • Jun 1, 2026

    Grew 38% QoQ from 8 to 11 employees.

Oculera Health Filings

Explore SEC and related filing metadata, where available.

Oculera Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oculera Health's valuation, stock price, and market status.

Is Oculera Health a public or private company?

Oculera Health is a private company.

What is the current stock price of Oculera Health?

Oculera Health is a private company, so its shares have no public market price. Caplight tracks Oculera Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Oculera Health worth (valuation)?

Valuation information for Oculera Health is not publicly available.

Can I buy Oculera Health stock?

Oculera Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Oculera Health's last funding round?

Oculera Health's most recent funding round was Seed on November 24, 2025.

Who are the main investors in Oculera Health?

Investor information for Oculera Health is not publicly disclosed.

Will Oculera Health IPO soon?

No public IPO plans have been announced for Oculera Health.

How can I track Oculera Health secondary market activity?

Caplight tracks bids, offers, and trades in Oculera Health's shares on secondary markets.

Firmographic Details

HeadquartersTurkey
Employee Range13
Year FoundedN/A
Last FundingNov 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?